http://www.epizyme.com
Epizyme, Inc. Company Intro
Epizyme is a clinical stage biopharmaceutical company creating novel epigenetic therapies for people with cancer
Industry
Healthcare
Epizyme, Inc. Headquaters
400 Technology Square
Cambridge,02139
United States
Epizyme, Inc. Share price
14 Sep 2022 09:09 GMT
$1.4900
0.02 (1.36 %)
Epizyme, Inc. Market cap
$152.726 M
WMC RANKING
2023
Epizyme, Inc. # 149
BiotechnologyLatest Epizyme, Inc. News
27 Mar 2023
Hodgkin Lymphoma Pipeline Report provides Therapeutic ...
Hodgkin Lymphoma Pipeline Report provides Therapeutic ...
27 Mar 2023
100+ Leading Multiple Myeloma Pipeline Companies are ...
Epizyme now operates as 'an Ipsen company' at deal close. ... In June 2021, AbbVie and Teneobio, Inc. announced that AbbVie exercised its exclusive right to...
27 Mar 2023
Hodgkin Lymphoma Pipeline Report provides Therapeutic ...
In August 2021, HUTCHMED Limited and Epizyme, Inc. announced a collaboration ... 3P Biopharmaceuticals (3P) and Norwegian biopharmaceutical company Nordic...
WMC Market Score
WMC Market to Revenue Score
Epizyme, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Epizyme, Inc. | USD | $22,039 | $253,136 | $-251,031 | $1,527M | 149 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $754,300B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $713,610B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Epizyme, Inc. Social Followers vs Top 4 Industry Competitors
Epizyme, Inc. Post vs Top 4 Industry Competitors
Epizyme, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Epizyme, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Epizyme, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Epizyme, Inc. | 0.24 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 22 | 0 | 0 | 28.52 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 33 | 0 | 0 | 34.78 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 47.37 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
